Particle.news
Download on the App Store
4 ARTICLES
·
last mo.

Brazil Approves New Gardasil 9 Indication for Oropharyngeal and Other Head and Neck Cancers

Anvisa says the decision rests on data showing prevention of persistent infection by high‑risk HPV types.

Image
Image

Overview

  • Eligibility now spans children, men and women ages 9 to 45.
  • Regulators highlight a rise in HPV‑related oropharyngeal tumors, particularly among younger adults, as a key public‑health concern.
  • Before this change, Gardasil 9 already covered cervical, vulvar, vaginal and anal cancers, precancerous lesions, genital warts and persistent HPV infection.
  • Health authorities recommend vaccination before sexual debut, with potential benefits for older individuals who have not encountered the vaccine‑covered HPV types.
  • The nonavalent vaccine is currently offered in the private sector, while the public program provides a single quadrivalent dose for 9–14‑year‑olds and immunosuppressed people up to 45, with a catch‑up option for 15–19 through June.